US 8338569
FGFR extracellular domain acidic region muteins
granted A61KA61K38/177A61K38/179
Quick answer
US patent 8338569 (FGFR extracellular domain acidic region muteins) held by Five Prime Therapeutics, Inc. expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/177, A61K38/179, A61P, A61P27/02